Sort
34,240 grants matching “atherosclerosis”
MINERALOCORTICOID RECEPTOR ANTAGONISM CLINICAL EVALUATION IN ATHEROSOCLEROSIS (MAGMA)
$616,422Sanjay Rajagopalan · Case Western Reserve University · R01 · FY2019 · HL
Lupus Cohort
$616,409Johns Hopkins University · R01 · FY2005 · AR
Enhanced carotid bifurcation phantom for MRI/A
$616,394Phantoms By Design, Inc · R44 · FY2002 · HL
Inflammation and Cardiovascular Disease in RA
$616,356Johns Hopkins University · R01 · FY2005 · AR
Social and geographic predictors of heterogeneity in cardiovascular risk in Afric
$616,238Ana V Diez Roux · University Of Michigan At Ann Arbor · P60 · FY2008 · MD
A hypercholesterolemia-induced immunometabolite in atherosclerosis
$616,205Prediman Krishan Shah · Cedars-Sinai Medical Center · R01 · FY2023 · HL
Translational Research of Negative Emotions and Acute Endothelial Dysfunction
$616,170Daichi Shimbo · Columbia University Health Sciences · R01 · FY2017 · HL
Genetic Markers of CHD in Type 2 Diabetes
$616,133Harvard University (Sch Of Public Hlth) · R01 · FY2005 · HL
Molecular Biology of Stroke in Humans
$616,086Frank R Sharp · University Of California At Davis · R01 · FY2014 · NS
Identification and study of the vascular disease gene at 9p21.3
$615,620Thomas None Quertermous · Stanford University · R01 · FY2012 · HL
Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
$615,578Robert G Weiss · Johns Hopkins University · R01 · FY2017 · HL
FHS-Molecular Genetics &Genetic Epidemiology
$615,523Washington University · R01 · FY2001 · HL
Low-level Arsenic Exposure and Cardiovascular Disease in Multi-Ethnic Adults (MESA As)
$615,499Ana Navas-Acien · Columbia University Health Sciences · R01 · FY2021 · ES
Race/Ethnicity, DNA Methylation, and Disparities in Cardiovascular Mortality: NHANES 1999-2002
$615,481Belinda L. Needham · University Of Michigan At Ann Arbor · R01 · FY2019 · MD
Family Study of Carotid Atherosclerosis and Stroke Risk
$615,412Tatjana Rundek · University Of Miami School Of Medicine · R01 · FY2020 · NS
Mechanosensors that detect and treat Lung Fibrosis
$615,406Thomas Harrison Barker · University Of Virginia · R01 · FY2019 · HL
Determinants of Accelerated CVD in Type 1 Diabetes
$615,379University Of Colorado Denver · R01 · FY2005 · HL
Targeting RAGE/DIAPH1: Novel Therapeutic Strategy for Diabetic Complications
$615,294Ann Marie Schmidt · New York University School Of Medicine · R01 · FY2023 · DK
Development, testing, and implementation of virtual statin associated muscle symptom (SAMS) management
$615,151Jordan Bradley King · University Of Utah · R01 · FY2022 · HL
Long-Term Cardiovascular Sequelae of Cancer Immunotherapies
$615,145Javid J Moslehi · University Of California, San Francisco · R01 · FY2025 · HL
Clonal hematopoiesis of indeterminate potential and HIV in the REPRIEVE trial
$615,128Pradeep Natarajan · Massachusetts General Hospital · R01 · FY2023 · HL
Clonal hematopoiesis of indeterminate potential and HIV in the REPRIEVE trial
$615,128Pradeep Natarajan · Massachusetts General Hospital · R01 · FY2022 · HL
Age, Gene/Environment Susceptibility Study
$614,998Tamara Harris · National Institute On Aging · ZIA · FY2010 · AG
Polymorphic ApoE at the crossroad of lipid metabolism and inflammation in atherosclerosis
$614,941David Y Hui · University Of Cincinnati · R01 · FY2022 · HL
Polymorphic ApoE at the crossroad of lipid metabolism and inflammation in atherosclerosis
$614,941David Y Hui · University Of Cincinnati · R01 · FY2023 · HL